1381/1507US=47 / Imagem
Eifel PJ. Intensity-modulated radiation therapy for carcinomas of the uterine cervix and endometrium. In: Bortfeld T, Schmidt-Ulrich R, de Neve W, Wazer DE. Image-Guided IMRT. Berlin: Springer, 2006. p. 411-22. ISBN 3-540-20511-X.

RADIOTERAPIA DE INTENSIDADE MODULADA; CARCINOMA DO COLO UTERINO; CARCINOMA DO ENDOMETRIO

1382/1507US=14 / Urologia
Warde PR, Smalley SR. Testis cancer: radiation therapy for testicular seminoma. In: Vogelzang NJ, Scardino PT, Shipley WU, Debruyne FMJ, Linehan WM. Comprehensive textbook of genitourinary oncology. 3ª ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 629-37. ISBN 978-0-7817-4984-0.

CANCER DE TESTICULO; RADIOTERAPIA; TERAPIA DE RADIACAO; SEMINOMA TESTICULAR; TOXICICIDADE DA RADIACAO

1383/1507US=14 / Urologia
Sleijfer S, Wit R. Testis cancer: risk-adapted therapy of metastatic testis cancer: risk-adapted therapy of metastatic testis cancer: good-risk patients. In: Vogelzanj NJ, Scardino PT, Shipley WU, Debruyne FMJ, Linehan WM. Comprehensive textbook of genitourinary oncology. 3ª ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 639-45. ISBN 978-0-7817-4984-0.

CANCER DE TESTICULO. TERAPIA; CANCER TESTICULAR METASTATICO; BLEOMICINA; ETOPOSIDE; CISPLATINA; CARBOPLATINA; SEMINOMA; NAO SEMINOMA

1384/1507US=14 / Urologia
Crook JM. Penile cancer: radiation therapy for penile cancer. In: Vogelzang NJ, Scardino PT, Shipley WU, Debruyne FMJ, Linehan WM. Comprehensive textbook of genitourinary oncology. 3ª ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 819-26. ISBN 978-0-7817-4984-0.

CANCER DE PENIS; RADIOTERAPIA; TECNICAS RADIOTERAPICAS; TOXICIDADE

1385/1507US=47 / Clín/Medica
Rossouw JE. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 444-61. ISBN 978-1-57331-699-5.

ESTROGENIO; PROGESTINA; TERAPIA HORMONAL POS-MENOPAUSA; DOENCA CARDIOVASCULAR; MULHERES

1386/1507US=49-A / Câncer
Choudhury A, Mosolits S, Kokhaei P, Hansson L, Palma M, Mellstedt H. Clinical results of vaccine therapy for cancer: learning from history for improving the future. In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2006. p. 147-202. ISBN 978-0-12-006695-7.

CANCER; VACINA; RESULTADOS CLINICOS; DOENCAS DE CELULAS B; ENSAIOS DE VACINAS; LEUCEMIA LINFOCITICA CRONICA DE CELULAS B; MIELOMA MULTIPLO; CARCINOMA DE CELULAS RENAIS; CANCER DE PROSTATA; MELANOMA; CANCER GASTROINTESTINAL; CANCER GINECOLOGICO; CANCER DE PULMAO; CANCER DE MAMA

1387/1507US=55 / Biol/Mol
Pastor-Anglada M, Casado FJ. Nucleoside transport into cells: role of nucleoside transporters SLC28 and SLC29 in cancer chemotherapy. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 1-28. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5.

CANCER; QUIMIOTERAPIA; TRANSPORTE DE NUCLEOSIDEOS; SLC28; SLC29; CONCENTRACAO DE TRANSPORTADOR NUCLEOSIDEO; TRANSPORTADOR NUCLEOSIDO DE EQUILIBRIO; CAPTACAO DE NUCLEOSIDEO; DIFUSAO PASSIVA

1388/1507US=55 / Biol/Mol
Staub M, Eriksson S. The role of deoxycytidine kinase in DNA synthesis and nucleoside analog activation. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 29-52. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5.

DESOXICITIDINA-QUINASE; SINTESE DE DNA; ATIVACAO ANALOGO DE NUCLEOSIDEO; DESOXICITIDINA QUINASE; QUINASE DEOXIGUANOSINE; ANALOGOS DESOXINUCLEOSIDOS; DESOXINUCLEOSIDO QUINASE; TIMIDINA QUINASE

1389/1507US=55 / Biol/Mol
Munch-Petersen B, Piskur J. Deoxynucleoside kinases and their potential role in deoxynucleoside cytotoxicity. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 53-79. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5.

QUINASES DESOXINUCLEOSIDOS; CITOTOXICIDADE; DEOXIRIBONUCLEOSIDEOS; QUINASE; ANALOGOS NUCLEOSIDEOS; QUIMIOTERAPIA

1390/1507US=55 / Biol/Mol
Hunsucker SA, Mitchell BS, Spychala J. Nucleotidases and nucleoside analog cytotoxicity. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 81-108. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5.

NUCLEOTIDASES; CITOTOXICIDADE; ANALOGO DE NUCLEOSIDEO; METABOLISMO DE DROGAS; RESISTENCIA AS DROGAS; ANALOGOS NUCLEOSIDEOS; 5-NUCLEOTIDASE

1391/1507US=55 / Biol/Mol
Borst P, Wielinga P. Pumping out drugs: the potential impact of ABC transporters on resistance to base, nucleoside, and nucleotide analogs. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 109-17. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5.

BOMBEANDO DE MEDICAMENTOS; TRANSPORTADORES ABC NA RESISTENCIA A BASE; ANALOGOS DE NUCLEOSIDEOS; NUCLEOTIDEOS; BCRP; BOMBAS DE EFLUXO; MRP4; MRP5; RESISTENCIA MULTIDROGA DE PROTEINAS; MONOFOSFATOS NUCLEOSIDEOS; PMEA; TIOPURINAS

1392/1507US=55 / Biol/Mol
Hubeek I, Kaspers GJL, Ossenkoppele GJ, Peters GJ. Cytosine arabinoside: metabolism, mechanisms of resistance, and clinical pharmacology. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 119-52. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5.

CITOSINA ARABINOSIDO; METABOLISMO; MECANISMOS DE RESISTENCIA; FARMACOLOGIA CLINICA; LEUCEMIA MIELOIDE AGUDA; MODULACAO BIOQUIMICA; CITARABINE ARABINOSIDE; DESOXICITIDINA QUINASE; ALTA DOSE DE ARA-C; FLAG; FLUDARABINA

1393/1507US=55 / Biol/Mol
Gandhi V, Plunkett W. Clofarabine: mechanisms of action, pharmacology, and clinical investigations. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 153-71. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5.

CLOFARABINA; MECANISMOS DE ACAO; FARMACOLOGIA; INVESTIGACOES CLINICAS; LEUCEMIA AGUDA; FARMACOLOGIA CELULAR; CLADRIBINA; CLOFARABINA; POLIMERASE DNA; REPARO DE DNA; FLUDARABINA

1394/1507US=55 / Biol/Mol
Gumina G, Chong Y, Chu CK. L-nucleosides as chemotherapeutic agents. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 173-98. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5.

L-NUCLEOSIDEOS; AGENTES QUIMIOTERAPEUTICOS; AGENTES ANTICANCERIGENOS; AGENTES ANTIVIRAIS; DEOXICITIDINA QUINASE; L-NUCLEOSIDES; TROXACITABINA; LAMIVUDINA; EMTRICITABINA; TELBIVUDINA; VALTORCITABINE; CLEVUDINE; ELVUCITABINE

1395/1507US=55 / Biol/Mol
Gourdeau H, Jolivet J. Troxacitabine (troxatyl): a deoxycytidine nucleside analog with potent antitumor activity. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 199-214. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5.

TROXACITABINE; TROXATYL; ANALOGO NUCLESIDE DEOXICITIDINE; ATIVIDADE ANTITUMORAL; QUIMIOTERAPIA; TRATAMENTO CLINICO; NEOPLASIAS HEMATOLOGICAS; TUMORES SOLIDOS

1396/1507US=55 / Biol/Mol
Curbo S, Karlsson A. 9-beta-D-arabinofuranosylguanine. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 215-24. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5.

9-BETA-D-ARABINOFURANOSILGUANINA; ANTICANCERIGENOS; ANALOGO DEOXIGUANOSINA; DEOXIGUANOSINA QUINASE; DEOXINUCLEOSIDE QUINASE MITOCONDRIAL; NELARABINA; NEOPLASIAS DE CELULAS T

1397/1507US=55 / Biol/Mol
Bergman AM, Peters GJ. Gemcitabine: mechanism of action and resistance. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 225-51. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5.

GEMCITABINE; MECANISMO DE ACAO; RESISTENCIA; DESOXICITIDINA QUINASE; REPARO DO DNA; TERMINACAO DA CADEIA MASCARADO; RIBONUCLEOTIDO REDUTASE; AUTO-POTENCIALIZACAO; TIMIDINA QUINASE 2

1398/1507US=55 / Biol/Mol
Kroep JR, Peters GJ, Nagourney RA. Clinical activity of gemcitabine as a single agent and in combination. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 253-88. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5.

GEMCITABINA; ATIVIDADE CLINICA; CANCER DE MAMA; CISPLATINA; CANCER DE PULMAO DE CELULAS NAO-PEQUENAS; CANCER DE OVARIO; CANCER DE PANCREAS; RADIOTERAPIA; TAXANE

1399/1507US=55 / Biol/Mol
Shewach DS, Lawrence TS. Nucleoside radiosensitizers. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 289-329. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5.

RADIOSSENSIBILIZADORES NUCLEOSIDEOS; REPARO DO DNA; FLUDARABINA; FLUORODEOXIURIDINA; 5-FLUOROURACIL; GEMCITABINA; RADIACAO; RADIOSSENSIBILIZACAO

1400/1507US=55 / Biol/Mol
Avramis VI. NONMEM population models of cytosine arabinoside and fludarabine phosphate in pediatric patients with leukemia. In: Peters GJ. Deoxynucleoside analogs in cancer therapy. New Jersey: Humana Press, 2006. p. 331-52. (Cancer Drug Discovery and Development) ISBN 978-1-58829-327-5.

NONMEM; CITOSINA DE ARABINOSIDE; FOSFATO DE FLUDARABINA; PACIENTES PEDIATRICOS; LEUCEMIA; LEUCEMIA LINFOBLASTICA AGUDA; VOLUME DE DISTRIBUICAO

Primeira | Anterior | Próxima | Última